632 related articles for article (PubMed ID: 1285245)
1. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.
Amitrano L; Ascione A; Canestrini C; D'Agostino S; Iaccarino L; Vacca C; Gigliotti T
Ital J Gastroenterol; 1990 Feb; 22(1):16-8. PubMed ID: 1966702
[TBL] [Abstract][Full Text] [Related]
3. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years.
Kondili LA; Cuko L; Chionne P; Candido A; Madonna E; Dentico P; Resuli B; Taliani G; Brunetto MR; Rapicetta M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):167-71. PubMed ID: 19734797
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies against hepatitis C virus in patients with liver diseases and in risk subjects. Preliminary report].
Garassini MA; Ortega F; Valdés A; Alvarado M; Cid A; Serrano L; Torres G; Hagen E; Dugarte I; Pérez N
G E N; 1990; 44(4):343-8. PubMed ID: 1967087
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis virus (HBV, HCV, HDV) markers in chronic liver diseases. Comparative studies in two East-Central European countries].
Pár A; Luminita S; Erdósy I; Doru D; Kádas I; Paál M; Brasch G; Beró T; Jávor T
Orv Hetil; 1992 Jul; 133 Suppl 1():48-50. PubMed ID: 1321399
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus antibodies in chronic liver diseases of different aetiology.
Craxi A; Almasio P; Di Marco V; Magrin S; Bruno R; Cammà C; Fiorentino G; Lo Jacono O; Marino L; Palazzo U
Ital J Gastroenterol; 1991 Jun; 23(5):244-8. PubMed ID: 1742513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
